It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
As a first host barrier, the skin is constantly exposed to environmental insults that perturb its integrity. Tight regulation of skin homeostasis is largely controlled by the aryl hydrocarbon receptor (AhR). Here, we demonstrate that Henna and its major pigment, the naphthoquinone Lawsone activate AhR, both in vitro and in vivo. In human keratinocytes and epidermis equivalents, Lawsone exposure enhances the production of late epidermal proteins, impacts keratinocyte differentiation and proliferation, and regulates skin inflammation. To determine the potential use of Lawsone for therapeutic application, we harnessed human, murine and zebrafish models. In skin regeneration models, Lawsone interferes with physiological tissue regeneration and inhibits wound healing. Conversely, in a human acute dermatitis model, topical application of a Lawsone-containing cream ameliorates skin irritation. Altogether, our study reveals how a widely used natural plant pigment is sensed by the host receptor AhR, and how the physiopathological context determines beneficial and detrimental outcomes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Max Planck Institute for Infection Biology, Charitéplatz 1, Department of Immunology, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699)
2 Max Planck Institute for Infection Biology, Charitéplatz 1, Department of Immunology, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699); University of Oxford, Nuffield Department of Clinical Medicine, Ludwig Institute for Cancer Research, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
3 NOVA University of Lisbon, CEDOC, NOVA Medical School, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713)
4 Human Genomics Laboratory - University of Medicine and Pharmacy of Craiova, Craiova, Romania (GRID:grid.413055.6) (ISNI:0000 0004 0384 6757)
5 Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, Berlin, Germany (GRID:grid.418832.4) (ISNI:0000 0001 0610 524X)
6 University of Medicine and Pharmacy of Craiova, Research Center of Gastroenterology and Hepatology, Craiova, Romania (GRID:grid.413055.6) (ISNI:0000 0004 0384 6757)
7 Max Planck Institute for Infection Biology, Charitéplatz 1, Microarray Core Facility, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699)
8 Max Planck Institute for Infection Biology. Charitéplatz 1, Biochemistry and Protein Purification Core Facility, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699)
9 INEM (Institut Necker-Enfants Malades), CNRS UMR8253, INSERM UMR1151 and Paris Descartes University, Laboratory of Immunoregulation and Immunopathology, Paris, France (GRID:grid.10992.33) (ISNI:0000 0001 2188 0914)
10 Charité-Universitätsmedizin Berlin, Department of Dermatology and Allergy, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662)
11 Max Planck Institute for Infection Biology, Charitéplatz 1, Department of Immunology, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699); Texas A&M University, Hagler Institute for Advanced Study, College Station, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082)